Resources|Podcasts|March 28, 2025
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
Author(s)PPD, Thermo Fisher Scientific
As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
From AI to Smart Factories: How Pharma Is Preparing for 2026
2
Industry Outlook 2026: Success through Top Talent, AI Utilization, and Sustainability
3
HITL and HOTL: An Air Traffic Control Analogy for Agentic AI
4
Double Cone Tumble Blender Provides Homogeneity in Heavy-Duty Applications
5